$ Value
$63K
Shares
14,827
Price
$4
Filed
Jul 8
Insider
Name
Kelly John Alexander
Title
Chief Financial Officer
CIK
0001590030
Roles
Transaction Details
Transaction Date
2025-07-03
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
73,485
Footnotes
The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the settlement of 44,368 RSUs which vested on January 20, 2025. The settlement occurred on July 3, 2025, as approved by the Issuer's Compensation Committee. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. | Includes 2,056 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $7.21.
Filing Info
Kelly John Alexander's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | DTIL | ▼ | $31K |
| 2026-02-17 | DTIL | M | $0 |
| 2026-02-17 | DTIL | M | $0 |
| 2026-01-21 | DTIL | ▼ | $61K |
| 2026-01-20 | DTIL | M | — |
| 2026-01-20 | DTIL | M | — |
| 2026-01-20 | DTIL | M | — |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
Other Insiders at DTIL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kelly John Alexander
Chief Financial Officer
|
— | $31K | 2026-02-18 |
|
SMITH J. JEFFERSON
Chief Research Officer
|
— | $19K | 2026-02-18 |
|
Scimeca Dario
General Counsel and Secretary
|
— | $19K | 2026-02-18 |
|
Amoroso Michael
President and CEO
|
— | $79K | 2026-02-18 |